References
Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation. N Engl J Med 306: 1018–1022
Benaim R, Uzan C (1978) Les effects antiarythmiques de l'amiodarone injectable. Rev Med 19: 1959–1963
Schwartz JB (1983) Verapamil in atrial fibrillation: the expected, the unexpected, and the unknown. Am Heart J 106: 173–175
Fenster PE, Comess KA, Marsh R, Katzenberg C, Hager WD (1983) Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J 106: 501–504
Deano CU, Wu D, Mautner RK, Sherman RH, Ehsani AE, Rosen SM (1977) The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Chest 71: 597–606
Stern S (1967) Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment. Am Heart J 74: 170–172
Hodges AB, Follansbee WP, Spear JF, Moore EN (1979) Electrophysiological effects of a new antiarrhyhmic agent, flecainide, on the intact canine heart. J Cardiovasc Pharmacol 1: 427
Hellestrand KJ, Nathan AW, Bexton RS, Spurell RAJ, Camm AJ (1983) Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. Am J Cardiol 51: 770–776
Hodges M, Haugland JM, Granrud G, Conrad GJ, Asinger RW, Mikell FL, Krejci J (1982) Suppression of ventricular ectopic depolarisations by flecainide acetate, a new antiarrhythmic agent. Circulation 65: 5, 879–885
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goy, J.J., Maendly, R., Grbic, M. et al. Cardioversion with flecainide in patients with atrial fibrillation of recent onset. Eur J Clin Pharmacol 27, 737–738 (1985). https://doi.org/10.1007/BF00547059
Issue Date:
DOI: https://doi.org/10.1007/BF00547059